Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

The tolerability issue of generic imatinib in patients with chronic myeloid leukemia (Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293).

Eskazan AE, Soysal T.

Haematologica. 2019 Jul;104(7):e330. doi: 10.3324/haematol.2019.222000. No abstract available.

2.

The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.

Soysal T, Eskazan AE, Serin I, Sadri S, Keskin D, Ozgur Yurttas N, Berk S, Erdogan Ozunal I, Salihoglu A, Ar MC, Ongoren S, Baslar Z, Ozbek U, Aydin Y.

Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e377-e384. doi: 10.1016/j.clml.2019.03.028. Epub 2019 Apr 4.

PMID:
31088736
3.

Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience

Öngören S, Salihoğlu A, Apaydın T, Sadri S, Eşkazan AE, Ar MC, Elverdi T, Başlar Z, Aydın Y, Soysal T.

Balkan Med J. 2018 Nov 15;35(6):417-421. doi: 10.4274/balkanmedj.2017.1215. Epub 2018 Jul 3.

4.

Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.

Erbilgin Y, Eskazan AE, Hatirnaz Ng O, Salihoglu A, Elverdi T, Firtina S, Tasar O, Mercan S, Sisko S, Khodzhaev K, Ongoren S, Ar MC, Baslar Z, Soysal T, Sayitoglu M, Ozbek U.

Leuk Lymphoma. 2019 Jan;60(1):200-207. doi: 10.1080/10428194.2018.1473573. Epub 2018 Jul 2.

PMID:
29965782
5.

Results of the Hematology Laboratory Survey: What has Changed in Eight Years?

Kozanoğlu İ, Patıroğlu T, Dalva K, Yanıkkaya Demirel G, Soysal T, Demir M.

Turk J Haematol. 2018 Aug 3;35(3):215-216. doi: 10.4274/tjh.2018.0065. Epub 2018 Apr 18. No abstract available.

6.

Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience.

Öngören Ş, Eşkazan AE, Berk S, Elverdi T, Salihoğlu A, Ar MC, Başlar Z, Aydın Y, Tüzüner N, Soysal T.

Turk J Haematol. 2017 Dec 1;34(4):291-299. doi: 10.4274/tjh.2016.0443.

7.

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.

Ongoren S, Eskazan AE, Suzan V, Savci S, Erdogan Ozunal I, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Erbilgin Y, Iseri SA, Ar MC, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Hematology. 2018 May;23(4):212-220. doi: 10.1080/10245332.2017.1385193. Epub 2017 Oct 9. Review.

PMID:
28990873
8.

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.

Eskazan AE, Sadri S, Keskin D, Ayer M, Kantarcioglu B, Demirel N, Aydin D, Aydinli F, Yokus O, Ozunal IE, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Ongoren S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):804-811. doi: 10.1016/j.clml.2017.07.255. Epub 2017 Aug 4.

PMID:
28847475
9.

Comment and response to: the significance of early warning in chronic myeloid leukemia.

Eskazan AE, Ar MC, Soysal T.

Expert Rev Hematol. 2018 Apr;11(4):267-268. doi: 10.1080/17474086.2017.1340719. Epub 2017 Jun 15. No abstract available.

PMID:
28598700
10.

Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors.

Yalnız FF, Akkoç N, Salihoğlu A, Ar MC, Öngören Ş, Eşkazan AE, Soysal T, Aydın Y.

Turk J Haematol. 2017 Aug 2;34(3):233-238. doi: 10.4274/tjh.2016.0397. Epub 2017 Mar 8.

11.

Personalized prophylaxis in people with hemophilia A: challenges and achievements.

Ar MC, Baslar Z, Soysal T.

Expert Rev Hematol. 2016 Dec;9(12):1203-1208. Epub 2016 Nov 4. Review.

PMID:
27809624
12.

Critical appraisal of European LeukemiaNet (ELN) 2013 recommendations for the management of chronic myeloid leukemia: is it early for a warning?

Eskazan AE, Ar MC, Soysal T.

Expert Rev Hematol. 2016 Oct;9(10):919-21. doi: 10.1080/17474086.2016.1231572. Epub 2016 Sep 8. No abstract available.

PMID:
27606433
13.

Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha.

Salihoglu A, Elverdi T, Eskazan AE, Eyice D, Bavunoglu I, Ar MC, Ongoren S, Guzel E, Baslar Z, Tunckale A, Tuzuner N, Soysal T.

Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):272-7. doi: 10.1007/s12288-015-0600-8. Epub 2015 Sep 21.

14.

Treatment of patients with immune thrombocytopenia admitted to the emergency room.

Bavunoğlu I, Eşkazan AE, Ar MC, Cengiz M, Yavuzer S, Salihoğlu A, Öngören Ş, Tunçkale A, Soysal T.

Int J Hematol. 2016 Aug;104(2):216-22. doi: 10.1007/s12185-016-2003-5. Epub 2016 Apr 29.

PMID:
27129318
15.

Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates.

Tekgündüz E, Şencan İ, Kapuağası A, Ünal D, Öztürk M, Gümüş E, Göker H, Tavil EB, Ertem M, Çetin M, Arat M, Soysal T, Karakaşlı O, Sur HY, Yeşilipek A, Ferhanoğlu B, Uçkan D, İlhan O, Altuntaş F.

Transfus Apher Sci. 2016 Feb;54(1):53-9. doi: 10.1016/j.transci.2016.01.013. Epub 2016 Jan 11.

PMID:
26899916
16.

Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia.

Tanrikulu Simsek E, Eskazan AE, Cengiz M, Ar MC, Ekizoglu S, Salihoglu A, Gulturk E, Elverdi T, Ongoren Aydin S, Senem Demiroz A, Buyru AN, Baslar Z, Ozbek U, Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T.

J Clin Pathol. 2016 Sep;69(9):810-6. doi: 10.1136/jclinpath-2015-203320. Epub 2016 Jan 25.

PMID:
26811428
17.

Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide.

Salihoglu A, Ar MC, Soysal T.

Expert Rev Hematol. 2015 Dec;8(6):765-83. doi: 10.1586/17474086.2015.1091301. Epub 2015 Sep 28. Review.

PMID:
26413907
18.

Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.

Işlak Mutcalı S, Saltoğlu N, Balkan İİ, Özaras R, Yemişen M, Tabak F, Mert A, Öztürk R, Öngören Ş, Başlar Z, Aydın Y, Ferhanoğlu B, Soysal T.

Turk J Haematol. 2016 Dec 1;33(4):304-310. doi: 10.4274/tjh.2014.0385. Epub 2015 Aug 6.

19.

Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis.

Öztürk E, Özbalak M, Berk S, Erdoğan I, Avşar E, Dolgun A, Çetiner M, Mandel NM, Yalnız FF, Elverdi T, Salihoğlu A, Eşkazan AE, Ar MC, Öngören Ş, Başlar Z, Aydın Y, Soysal T, Ferhanoğlu B.

Leuk Lymphoma. 2016 May;57(5):1211-4. doi: 10.3109/10428194.2015.1079319. Epub 2015 Oct 12. No abstract available.

PMID:
26294270
20.

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.

Demirel A, Tabak F, Ar MC, Mete B, Öngören Ş, Yemişen M, Özaras R, Eşkazan E, Başlar Z, Mert A, Soysal T, Ferhanoğlu B, Aydın Y, Öztürk R.

Turk J Haematol. 2015 Sep;32(3):243-50.

21.

The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients.

Yemişen M, Balkan İİ, Salihoğlu A, Eşkazan AE, Mete B, Ar MC, Öngören Ş, Başlar Z, Özaras R, Saltoğlu N, Mert A, Ferhanoğlu B, Öztürk R, Tabak F, Soysal T.

Turk J Haematol. 2016 Sep 5;33(3):216-22. doi: 10.4274/tjh.2014.0378. Epub 2015 May 4.

22.

Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.

Eskazan AE, Hatemi İ, Öngören Aydın S, Ar MC, Soysal T.

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:233. doi: 10.5152/tjg.2014.5281. No abstract available.

23.

Recurrent Monosomies Confirmed by Interphase FISH in Three Chronic Myeloid Leukemia Cases.

Tarkan Argüden Y, Kuru D, Çırakoğlu A, Yılmaz Ş, Öngören Aydın Ş, Ar CM, Deviren A, Soysal T, Hacıhanefioğlu S.

Turk J Haematol. 2015 Mar 5;32(1):82-4. doi: 10.4274/tjh.2014.0374. No abstract available.

24.

Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both?

Eskazan AE, Erdogan I, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Soysal T.

Leuk Lymphoma. 2015;56(10):2995-6. doi: 10.3109/10428194.2015.1026819. Epub 2015 Mar 28. No abstract available.

PMID:
25747967
25.

A reappraisal of the association between Behçet's disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review.

Esatoglu SN, Hatemi G, Salihoglu A, Hatemi I, Soysal T, Celik AF.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S145-51. Epub 2015 Feb 9. Review.

PMID:
25664843
26.

Generic imatinib in the treatment of chronic myeloid leukemia: Cerrahpaşa experience.

Eskazan AE, Soysal T.

J Oncol Pharm Pract. 2016 Apr;22(2):382-4. doi: 10.1177/1078155215570766. Epub 2015 Feb 2.

PMID:
25644376
27.

Radotinib in the treatment of chronic phase chronic myeloid leukemia patients.

Eskazan AE, Soysal T.

Haematologica. 2015 Jan;100(1):e39. doi: 10.3324/haematol.2014.117846. No abstract available.

28.

Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options.

Çetin G, Eşkazan AE, Ar MC, Aydın ŞÖ, Ferhanoğlu B, Soysal T, Başlar Z, Aydın Y.

Turk J Haematol. 2014 Dec 5;31(4):374-80. doi: 10.4274/tjh.2013.0004.

29.

The current situation and future aspects of cost-effectiveness in chronic myeloid leukemia treatment.

Eskazan AE, Soysal T.

Leuk Lymphoma. 2015 May;56(5):1554-5. doi: 10.3109/10428194.2014.975701. Epub 2014 Nov 19. No abstract available.

PMID:
25330444
30.

Generics in chronic myeloid leukemia: current arguments for and against and the established evidence.

Soysal T, Eskazan AE, Ar MC.

Expert Rev Hematol. 2014 Dec;7(6):697-9. doi: 10.1586/17474086.2014.966679. Epub 2014 Oct 8.

PMID:
25292262
31.

The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?

Eskazan AE, Ar MC, Soysal T.

Leuk Lymphoma. 2015 Apr;56(4):1182-3. doi: 10.3109/10428194.2014.947609. Epub 2014 Aug 20. No abstract available.

PMID:
25093378
32.

Two cases of autoimmune hemolytic anemia secondary to brucellosis: a review of hemolytic disorders in patients with brucellosis.

Eskazan AE, Dal MS, Kaya S, Dal T, Ayyildiz O, Soysal T.

Intern Med. 2014;53(11):1153-8. Epub 2014 Jun 1. Review.

33.

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion.

Eskazan AE, Eyice D, Kurt EA, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Ferhanoglu B, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Leuk Res. 2014 Jul;38(7):781-7. doi: 10.1016/j.leukres.2014.04.004. Epub 2014 Apr 18.

PMID:
24832371
34.

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate.

Eskazan AE, Ayer M, Kantarcioglu B, Arica D, Demirel N, Aydin D, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Br J Haematol. 2014 Oct;167(1):139-41. doi: 10.1111/bjh.12937. Epub 2014 May 10. No abstract available.

PMID:
24815307
35.

The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia.

Eskazan AE, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Leuk Lymphoma. 2014 Dec;55(12):2935-7. doi: 10.3109/10428194.2014.905774. Epub 2014 May 6. No abstract available.

PMID:
24650055
36.

Bone marrow transplantation for Behçet's disease: a case report and systematic review of the literature.

Soysal T, Salihoğlu A, Esatoğlu SN, Gültürk E, Eşkazan AE, Hatemi G, Hatemi I, Öngören Aydın Ş, Erzin YZ, Başlar Z, Tüzüner N, Ferhanoğlu B, Çelik AF.

Rheumatology (Oxford). 2014 Jun;53(6):1136-41. doi: 10.1093/rheumatology/ket479. Epub 2014 Feb 6. Review.

PMID:
24505123
37.

Interstitial pneumonitis in a patient with chronic myeloid leukemia.

Eşkazan AE, Salihoğlu A, Erturan S, Soysal T.

Turk J Haematol. 2013 Dec;30(4):435-6. doi: 10.4274/Tjh.2012.0115. Epub 2013 Dec 5. No abstract available.

38.

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients.

Sahin F, Saydam G, Cömert M, Uz B, Yavuz AS, Turan E, Yönal I, Atay H, Keltikli E, Turgut M, Pehlivan M, Akay MO, Gürkan E, Paydaş S, Kahraman S, Demirkan F, Kırkızlar O, Akpınar S, Pamuk GE, Demir M, Ozbaş HM, Sönmez M, Gültürk M, Salihoğlu A, Eşkazan AE, Ar C, Haydaroğlu Şahin H, Ongören S, Başlar Z, Aydın Y, Yenere MN, Tüzüner N, Ferhanoğlu B, Haznedaroglu IC, Ilhan O, Soysal T.

Turk J Haematol. 2013 Dec;30(4):351-8. doi: 10.4274/tjh.2013.0151. Epub 2013 Dec 5.

39.

Ecthyma Gangrenosum-like Lesions in a Febrile Neutropenic Patient with Simultaneous Pseudomonas Sepsis and Disseminated Fusariosis.

Uludokumacı S, Balkan Iİ, Mete B, Ozaras R, Saltoğlu N, Soysal T.

Turk J Haematol. 2013 Sep;30(3):321-4. doi: 10.4274/Tjh.2012.0030. Epub 2013 Sep 5.

40.

Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia.

Eşkazan AE, Soysal T.

Turk J Haematol. 2013 Jun;30(2):211-3. doi: 10.4274/Tjh.2012.0013. Epub 2013 Jun 5. No abstract available.

41.

Simultaneous detection of B-cell chronic lymphocytic leukemia and colon adenocarcinoma in the same mesenteric lymph node.

Eşkazan AE, Berk S, Ozden F, Erdamar S, Tüzüner N, Soysal T.

Turk J Haematol. 2013 Mar;30(1):98-9. doi: 10.4274/tjh.2012.0169. Epub 2013 Mar 5. No abstract available.

42.

Postoperative thrombotic thrombocytopenic purpura.

Eskazan AE, Buyuktas D, Soysal T.

Surg Today. 2015 Jan;45(1):8-16. doi: 10.1007/s00595-013-0823-y. Epub 2013 Dec 29. Review.

PMID:
24374368
43.

Detailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective study.

Ozbalak M, Ar MC, Tuzuner N, Salihoglu A, Eskazan AE, Ongoren Aydin S, Baslar Z, Soysal T, Aydin Y, Barak Dolgun A, Ergonul O, Ferhanoglu B.

ISRN Hematol. 2013 Jul 30;2013:908191. doi: 10.1155/2013/908191. eCollection 2013.

44.

An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.

Salihoglu A, Ozbalak M, Keskin D, Tecimer T, Soysal T, Ferhanoglu B.

Transplant Proc. 2013 Sep;45(7):2845-8. doi: 10.1016/j.transproceed.2012.12.001. Epub 2013 Jun 6.

PMID:
23747187
45.

Analysis of activation-induced cytidine deaminase mRNA levels in patients with chronic lymphocytic leukemia with different cytogenetic status.

Gelmez MY, Teker AB, Aday AD, Yavuz AS, Soysal T, Deniz G, Aktan M.

Leuk Lymphoma. 2014 Feb;55(2):326-30. doi: 10.3109/10428194.2013.803225. Epub 2013 Jul 15.

PMID:
23662991
46.

The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms.

Arı MC, Büyüktaş D, Eşkazan AE, Ongören Aydın S, Tanrıkulu E, Başlar Z, Buyru AN, Ferhanoğlu B, Aydın Y, Tüzüner N, Soysal T.

Turk J Haematol. 2012 Sep;29(3):242-7. doi: 10.5505/tjh.2012.58751. Epub 2012 Oct 5.

47.

Pulmonary radiological findings in patients with acute myeloid leukemia and their relationship to chemotherapy and prognosis: a single-center retrospective study.

Buğdacı MS, Yanardağ H, Ar MC, Soysal T, Coşkun S, Demirci S.

Turk J Haematol. 2012 Sep;29(3):217-22. doi: 10.5152/tjh.2011.77. Epub 2012 Sep 15.

48.

Hypereosinophilic syndrome associated with simultaneous intracardiac thrombi, cerebral thromboembolism and pulmonary embolism.

Buyuktas D, Eskazan AE, Borekci S, Umut S, Ongen Z, Tuzuner N, Soysal T.

Intern Med. 2012;51(3):309-13. Epub 2012 Feb 1.

49.

JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome.

Ar MC, Hatemi G, Ekizoğlu S, Bilgen H, Saçli S, Buyru AN, Soysal T, Ülkü B, Yazici H.

Clin Appl Thromb Hemost. 2012 Jul;18(4):421-6. doi: 10.1177/1076029611427440. Epub 2011 Dec 26.

PMID:
22203033
50.

Synchronous Detection of Hairy Cell Leukemia and HIV-Negative Kaposi's Sarcoma of the Lymph Node: A Diagnostic Challenge and a Rare Coincidence.

Aydin SO, Eskazan AE, Aki H, Ozguroglu M, Baslar Z, Soysal T.

Case Rep Oncol. 2011 Sep;4(3):439-44. doi: 10.1159/000331894. Epub 2011 Sep 3.

Supplemental Content

Loading ...
Support Center